Improving cervical cancer screening and follow-up for underserved populations
Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)
This study is working to make cervical cancer screening easier and more effective for underserved communities, like urban Black and Haitian populations, Hispanic immigrants, and Hawaiian Natives, by using a proven method that combines education and support for healthcare providers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11099295 on NIH RePORTER |
What this research studies
This research aims to enhance cervical cancer screening and follow-up among underserved populations, particularly focusing on urban inner city Blacks/Haitians, Hispanic immigrants, and Hawaiian Natives/Pacific Islanders. The approach involves adapting a previously successful intervention that improved HPV vaccination rates by combining education with quality improvement methods. The intervention will be tested in diverse communities to ensure it effectively addresses barriers to screening and follow-up. By engaging healthcare providers through Performance Improvement Continuing Medical Education, the project seeks to improve cancer prevention practices while meeting certification requirements.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black, Hispanic, and low-income individuals who are at risk for cervical cancer and have not been screened in the past five years.
Not a fit: Patients who have been regularly screened for cervical cancer or those who do not belong to the targeted underserved populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates and reduce health disparities among vulnerable populations.
How similar studies have performed: Previous research has shown success in improving HPV vaccination rates using similar educational and quality improvement interventions.
Where this research is happening
Boston, United States
- Boston Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Lunze, Karsten — Boston Medical Center
- Study coordinator: Lunze, Karsten
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.